The World Health Organisation (WHO) and the US Food and Drug Administration (USFDA) have taken opposite stands on repurposed medicines (drugs used for treatment other than the intended) for COVID-19. Recently, remdesivir was approved by the USFDA to treat COVID-19 patients, while the WHO had said it had little or no effect on...
Full ArticleWHO and USFDA views on repurposed meds start a debate
Mid-Day
0 shares
1 views